On Monday, Biohaven Ltd (NYSE: BHVN) opened lower -3.33% from the last session, before settling in for the closing price of $13.5. Price fluctuations for BHVN have ranged from $13.04 to $55.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -49.78% annually for the last half of the decade. Company’s average yearly earnings per share was noted 16.89% at the time writing. With a float of $89.17 million, this company’s outstanding shares have now reached $102.10 million.
In an organization with 256 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Biohaven Ltd (BHVN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Biohaven Ltd is 12.68%, while institutional ownership is 88.84%. The most recent insider transaction that took place on Mar 04 ’25, was worth 996,238. In this transaction Director of this company bought 32,700 shares at a rate of $30.47, taking the stock ownership to the 2,320,571 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director bought 29,000 for $35.94, making the entire transaction worth $1,042,393. This insider now owns 2,368,741 shares in total.
Biohaven Ltd (BHVN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.89% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.05% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Check out the current performance indicators for Biohaven Ltd (BHVN). In the past quarter, the stock posted a quick ratio of 2.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.37, a number that is poised to hit -1.90 in the next quarter and is forecasted to reach -6.36 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Let’s dig in a bit further. During the last 5-days, its volume was 1.4 million. That was inferior than the volume of 1.62 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 16.92%.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 0.40%, which indicates a significant decrease from 3.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.84 in the past 14 days, which was lower than the 1.39 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.86, while its 200-day Moving Average is $31.14. However, in the short run, Biohaven Ltd’s stock first resistance to watch stands at $13.44. Second resistance stands at $13.83. The third major resistance level sits at $14.06. If the price goes on to break the first support level at $12.82, it is likely to go to the next support level at $12.59. Assuming the price breaks the second support level, the third support level stands at $12.20.
Biohaven Ltd (NYSE: BHVN) Key Stats
There are currently 102,113K shares outstanding in the company with a market cap of 1.33 billion. Presently, the company’s annual sales total 0 K according to its annual income of -846,420 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -221,680 K.
